Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2351255Generated: October 26, 2026

1-Heptyne → a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-ol

https://huagongshe.com/reaction/2351255

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-HeptyneHCID 12350—
ReactantLeukotriene B4HCID 5280492—
Reactant(-)-GlycidolHCID 6973630—
ReactantL-Ascorbic AcidHCID 54670067—
SolventDiethyl EtherHCID 3283—
Producta-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-olHCID 14464847—

Reaction Steps

The starting material for the process of this invention, compound 2, can be prepared as described in Nicolaou, K. C. et al., "A General and Stereocontrolled Total Synthesis of Leukotriene B4 and Analogues," J. Am. Chem. Soc., 106, 3548 (1984) or Hanson, R. M. and Sharpless, K. B., J. Org. Chem., 51 1922 (1986). Briefly, optically active (S)-glycidol THP ether is prepared from ascorbic acid as disclosed in Takano, S., Numata, H., Ogasawara, K., Heterocycles, 19, 237 (1982) and Baldwin, J. J., Raab, A. W., Mensler, K., Arison, B. H., McClure, D. E., J. Org. Chem., 43, 4876 (1978). The ether is reacted (-78°-25° C.) with two equivalents of the anion of 1-heptyne (1.0 equiv. of n-BuLi, 1.0 equiv. of TMEDA and THF, -78° C.) to afford a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-ol which is then silylated (t-BuPh2SiCl, imidazole, DMF) to, compound 2.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04873024
Source datasetuspto-grants-1989_10
ORD IDord-491ea872368f4a6580fbc8c0e583bfc3
Source noteuspto-grants-1989_10